New York assemblyman Pat Burke (D) filed a bill that would legalize psilocybin therapy and create a $2M grant program to ensure veterans and first responders can access the treatment.
If passed, therapists would be able to certify patients for psilocybin therapy after completing a two-hour training course through the Department of Health.
PDF of article
TripSitter Clinic Corp. now offers at-home ketamine therapy in 10 states!
The company, which is part of Origin Therapeutics’ portfolio, expanded its services to eight new states: Arizona, Colorado, Michigan, Washington, Florida, New York, Ohio, and Virginia, in addition to California and Illinois.
Patients can receive a prescription for oral ketamine after a virtual consultation a physician. They can then take the medication at home with virtual guidance, followed by therapy sessions.
Another company, My Ketamine Home, offers similar services in Texas, Florida, and California.
This week, the first-ever psychedelic billboard campaign debuted in Times Square to spark a conversation about the healing power of plant medicines and disrupt profit-driven ads.
The #CelebratePlantMedicine campaign encourages viewers to share their personal experiences with plant medicines to destigmatize the use of psychedelics. It also aims to amplify the importance of set and setting, integration, and respecting Indigenous wisdom.
The campaign is run by DoubleBling Magazine, Musings Magazine, Rainbo Mushrooms, and Honeysuckle Magazine, which ran Time Square’s first cannabis billboard.
Go share your story with the hashtag to join the movement!
A new bill proposed in New York would create a psychedelic research institute to study the effect of psilocybin, LSD, MDMA, and ibogaine on conditions including addictive disorders, depression, PTSD, and end-of-life anxiety. The bill is sponsored by Assemblywoman Linda Rosenthal (D), who believes that “psychedelics provide a host of benefits without the same risk of overdose or dependency that other medications may provide”. The legislature suggests that “psilocybin is a breakthrough therapy for severe depression and nicotine addiction” and may also provide treatment for methamphetamine or opioid addiction.
